Talis Biomedical Corp (TLIS)
9.16
+0.21
(+2.34%)
USD |
NASDAQ |
May 16, 16:00
9.15
-0.01
(-0.11%)
Pre-Market: 20:00
Talis Biomedical Profit Margin (Quarterly): -17.86K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -17.86K% |
December 31, 2023 | -8.91K% |
September 30, 2023 | -20.63K% |
June 30, 2023 | -31.32K% |
March 31, 2023 | -13.02K% |
Date | Value |
---|---|
December 31, 2022 | -25.17K% |
September 30, 2022 | -3.56K% |
June 30, 2022 | -5.38K% |
March 31, 2022 | -1.43K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-31.32K%
Minimum
Jun 2023
-1.43K%
Maximum
Mar 2022
-14.14K%
Average
-13.02K%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Retractable Technologies Inc | -0.51% |
Xtant Medical Holdings Inc | -15.31% |
Asensus Surgical Inc | -2.00K% |
Catheter Precision Inc | -3.26K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -69.15% |
Return on Assets | -52.92% |
Return on Invested Capital | -69.15% |
Gross Profit Margin (Quarterly) | 91.78% |
Operating Margin (Quarterly) | -19.34K% |
Return on Net Operating Assets | -368.6% |